专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20140113936A1 MEDICINAL TREATMENT OF DERMAL DISEASES IN COMPANION ANIMALS 有权
标题翻译：药物动物药物治疗灭鼠药物
公开(公告)号：US20140113936A1
公开(公告)日：2014-04-24
申请号：US14025302
申请日：2013-09-12
申请人： A.K. Gunnar Aberg , Vincent B. Ciofalo
发明人： A.K. Gunnar Aberg , Vincent B. Ciofalo
IPC分类号： A61K31/4535
CPC分类号： A61K31/4535 , A61K38/13
摘要： The methods disclosed herein relate to the treatment of skin infections in dogs, by-administering a therapeutically effective amount of norketotifen. Therapeutic antimicrobial activity of norketotifen against Malassezia sp. is described.
摘要翻译：本文公开的方法涉及治疗狗的皮肤感染，通过给予治疗有效量的诺托芬芬。诺卡非芬对马拉色菌属的治疗性抗微生物活性被描述。

2. 发明授权

US08778971B2 Medicinal treatment of dermal diseases in companion animals 有权
标题翻译：伴侣动物皮肤疾病的药物治疗
公开(公告)号：US08778971B2
公开(公告)日：2014-07-15
申请号：US14025302
申请日：2013-09-12
申请人： A.K. Gunnar Aberg , Vincent B. Ciofalo
发明人： A.K. Gunnar Aberg , Vincent B. Ciofalo
IPC分类号： A61K31/4535
CPC分类号： A61K31/4535 , A61K38/13
摘要： The methods disclosed herein relate to the treatment of skin infections in dogs, by administering a therapeutically effective amount of norketotifen. Therapeutic antimicrobial activity of norketotifen against Malassezia sp. is described.
摘要翻译：本文公开的方法涉及通过施用治疗有效量的诺替托芬来治疗狗中的皮肤感染。诺卡非芬对马拉色菌属的治疗性抗微生物活性被描述。

3. 发明申请

US20110294897A1 Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion 审中-公开
标题翻译：用化合物治疗弥漫性睑板腺分泌物的Xerophthalmia
公开(公告)号：US20110294897A1
公开(公告)日：2011-12-01
申请号：US12956386
申请日：2010-11-30
申请人： A.K. Gunnar Aberg , Vincent B. Ciofalo
发明人： A.K. Gunnar Aberg , Vincent B. Ciofalo
IPC分类号： A61K31/137 , A61P27/04
CPC分类号： A61K31/137 , A61K9/0019 , A61K9/0048 , A61K9/06 , A61K47/10
摘要： Methods for the treatment of patients suffering from dry eyes, by using adrenergic beta-receptor agonists, particularly salbutamol and in particular the optically pure or substantially pure R-enantiomer thereof. The embodiments disclosed herein include methods of increasing the Meibomian lipid secretion and thereby reducing or eliminating xerophthalmia symptoms by the administration of formulations containing therapeutically effective amounts of an adrenergic beta-receptor agonist to said patients. In particular, certain embodiments disclosed herein concern compositions that contain R-salbutamol as the active beta-receptor stimulating ingredient. In certain embodiments, the formulations are administered to the ocular surface of the eye and/or to the eyelid (the underside of the eyelid and/or the top of the eyelid) of a patient in need thereof.
摘要翻译：通过使用肾上腺素能β受体激动剂，特别是沙丁胺醇，特别是光学纯的或基本上纯的R-对映体，治疗患有干眼症的患者的方法。本文公开的实施方案包括通过向所述患者施用含有治疗有效量的肾上腺素能β受体激动剂的制剂来增加睑板腺脂质分泌并从而减少或消除干眼症状的方法。特别地，本文公开的某些实施方案涉及含有R-沙丁胺醇作为活性β-受体刺激成分的组合物。在某些实施方案中，将制剂施用于眼睛的眼表面和/或施用于有需要的患者的眼睑（眼睑的下侧和/或眼睑的顶部）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式